Poliovirus has served as the prototype virus for studying the replication mechanisms of picornaviruses and other (+) strand RNA viruses. The Picornaviridae family of small RNA viruses includes a large number of important pathogens. Some of the diseases associated with these viruses include meningitis, encephalitis, poliomyelitis, myocarditis, respiratory infections and hepatitis. In this study, we are using molecular genetic techniques to study poliovirus RNA replication in vitro and in vivo. We have developed new experimental methods that can be used in combination with classic viral genetic procedures in virus-infected cells. Using HeLa S10 in vitro translation-RNA replication reactions and preinitiation RNA replication complexes, we are investigating the viral replication cycle in vitro including viral protein synthesis, the cre(2C)-dependent synthesis of VPgpUpU, the synthesis of (-) and (+) strand RNA and the formation of infectious virus. Genetic complementation and RNA recombination assays are powerful methods to study the activities associated with trans-acting viral proteins and the cis-acting sequences and structures in the viral RNA. Since all of the viral replication proteins can be provided in trans in cell-free reactions, we are using genetic complementation assays to identify specific viral proteins and viral protein precursors that are required for the assembly of functional RNA replication complexes. We are also using complementation assays to identify and characterize cis-acting RNA sequences that are required for the initiation of (-) and (+) strand RNA synthesis. During the course of our recent studies, we have developed an in vitro recombination assay and methods to specifically assay for (-) and (+) strand RNA synthesis. Our basic experimental plan is to use these methods to answer questions of fundamental importance regarding the replication of poliovirus and other picornaviruses. In this renewal application, we are requesting funding that will include the following specific aims. (1) Identify and characterize the cis-acting replication elements in poliovirus genomic RNA. (2) Use a genetic complementation analysis to characterize the viral replication proteins and their precursors regarding their role in viral RNA replication. (3) Investigate the mechanisms involved in viral RNA recombination using an in vitro recombination assay. (4) Characterize the role of the 3' NTR and associated poly(A) tail in viral RNA replication.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI032123-09
Application #
6543686
Study Section
Virology Study Section (VR)
Program Officer
Meegan, James M
Project Start
1992-01-01
Project End
2007-04-30
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
9
Fiscal Year
2002
Total Cost
$217,500
Indirect Cost
Name
University of Florida
Department
Biochemistry
Type
Schools of Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Spear, Allyn; Ogram, Sushma A; Morasco, B Joan et al. (2015) Viral precursor protein P3 and its processed products perform discrete and essential functions in the poliovirus RNA replication complex. Virology 485:492-501
Ogram, Sushma A; Flanegan, James B (2011) Non-template functions of viral RNA in picornavirus replication. Curr Opin Virol 1:339-46
Spear, Allyn; Sharma, Nidhi; Flanegan, James Bert (2008) Protein-RNA tethering: the role of poly(C) binding protein 2 in poliovirus RNA replication. Virology 374:280-91
Silvestri, Lynn S; Parilla, Jessica M; Morasco, B Joan et al. (2006) Relationship between poliovirus negative-strand RNA synthesis and the length of the 3' poly(A) tail. Virology 345:509-19
Jurgens, Christy K; Barton, David J; Sharma, Nidhi et al. (2006) 2Apro is a multifunctional protein that regulates the stability, translation and replication of poliovirus RNA. Virology 345:346-57
Sharma, Nidhi; O'Donnell, Brian J; Flanegan, James B (2005) 3'-Terminal sequence in poliovirus negative-strand templates is the primary cis-acting element required for VPgpUpU-primed positive-strand initiation. J Virol 79:3565-77
Jurgens, Christy; Flanegan, James B (2003) Initiation of poliovirus negative-strand RNA synthesis requires precursor forms of p2 proteins. J Virol 77:1075-83
Morasco, B Joan; Sharma, Nidhi; Parilla, Jessica et al. (2003) Poliovirus cre(2C)-dependent synthesis of VPgpUpU is required for positive- but not negative-strand RNA synthesis. J Virol 77:5136-44
Barton, D J; O'Donnell, B J; Flanegan, J B (2001) 5' cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesis. EMBO J 20:1439-48
Barton, D J; Morasco, B J; Flanegan, J B (1999) Translating ribosomes inhibit poliovirus negative-strand RNA synthesis. J Virol 73:10104-12

Showing the most recent 10 out of 14 publications